Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome

Mei Jou Chen, Han Mo Chiu, Chi Ling Chen, Wei Shiung Yang, Yu Shih Yang, Hong Nerng Ho

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Context: Women with polycystic ovary syndrome (PCOS) have been implicated to have higher levels of alanine aminotransferase (ALT) because of the high prevalence of obesity. Objective: Our aim was to investigate the relationship between elevated ALT and aspartate aminotransferase (AST) activity and characteristic hyperandrogenism in women with PCOS. Design and Setting: We conducted a cross-sectional case-control study in a reproductive endocrinology clinic and voluntary annual medical health check-up program of the health management center in a tertiary medical center. Patients: A total of 279 women with PCOS and 279 age-frequency-matched healthy women were studied. Interventions: There were no interventions. Main Outcome Measures: All subjects underwent anthropometric measurement, clinical history recorded by questionnaires, and biochemical tests after an overnight fast. Results: The prevalence of elevated ALT and AST levels was significantly higher in women with PCOS than healthy control subjects. Multivariate regression analysis for women revealed that the presence of PCOS was significantly associated with elevated ALT but not AST after adjustment for age, obesity, and dyslipidemia. The level of androgenicity represented by free androgen index in women with PCOS was significantly related to elevated ALT and AST levels in multivariate regression models. Women with PCOS who had the highest quartile of free androgen index level had the highest risk of elevated ALT level after adjustment for age, obesity, insulin resistance, and dyslipidemia. Conclusions: The risk of elevated ALT level is significantly higher in women with PCOS than those without, independent of obesity. The elevated ALT levels in women with PCOS were associated with the increased androgen levels, independent of obesity, insulin resistance, and dyslipidemia.

Original languageEnglish
Pages (from-to)3332-3341
Number of pages10
JournalJournal of Clinical Endocrinology and Metabolism
Volume95
Issue number7
DOIs
Publication statusPublished - Jan 1 2010
Externally publishedYes

Fingerprint

Polycystic Ovary Syndrome
Alanine Transaminase
Aspartate Aminotransferases
Obesity
Androgens
Dyslipidemias
Endocrinology
Health
Insulin Resistance
Insulin
Hyperandrogenism
Regression analysis
Case-Control Studies
Healthy Volunteers
Multivariate Analysis
Regression Analysis
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome. / Chen, Mei Jou; Chiu, Han Mo; Chen, Chi Ling; Yang, Wei Shiung; Yang, Yu Shih; Ho, Hong Nerng.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 95, No. 7, 01.01.2010, p. 3332-3341.

Research output: Contribution to journalArticle

@article{54ca8ecac15246fbbf930dfd1cc89d73,
title = "Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome",
abstract = "Context: Women with polycystic ovary syndrome (PCOS) have been implicated to have higher levels of alanine aminotransferase (ALT) because of the high prevalence of obesity. Objective: Our aim was to investigate the relationship between elevated ALT and aspartate aminotransferase (AST) activity and characteristic hyperandrogenism in women with PCOS. Design and Setting: We conducted a cross-sectional case-control study in a reproductive endocrinology clinic and voluntary annual medical health check-up program of the health management center in a tertiary medical center. Patients: A total of 279 women with PCOS and 279 age-frequency-matched healthy women were studied. Interventions: There were no interventions. Main Outcome Measures: All subjects underwent anthropometric measurement, clinical history recorded by questionnaires, and biochemical tests after an overnight fast. Results: The prevalence of elevated ALT and AST levels was significantly higher in women with PCOS than healthy control subjects. Multivariate regression analysis for women revealed that the presence of PCOS was significantly associated with elevated ALT but not AST after adjustment for age, obesity, and dyslipidemia. The level of androgenicity represented by free androgen index in women with PCOS was significantly related to elevated ALT and AST levels in multivariate regression models. Women with PCOS who had the highest quartile of free androgen index level had the highest risk of elevated ALT level after adjustment for age, obesity, insulin resistance, and dyslipidemia. Conclusions: The risk of elevated ALT level is significantly higher in women with PCOS than those without, independent of obesity. The elevated ALT levels in women with PCOS were associated with the increased androgen levels, independent of obesity, insulin resistance, and dyslipidemia.",
author = "Chen, {Mei Jou} and Chiu, {Han Mo} and Chen, {Chi Ling} and Yang, {Wei Shiung} and Yang, {Yu Shih} and Ho, {Hong Nerng}",
year = "2010",
month = "1",
day = "1",
doi = "10.1210/jc.2009-2698",
language = "English",
volume = "95",
pages = "3332--3341",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "7",

}

TY - JOUR

T1 - Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome

AU - Chen, Mei Jou

AU - Chiu, Han Mo

AU - Chen, Chi Ling

AU - Yang, Wei Shiung

AU - Yang, Yu Shih

AU - Ho, Hong Nerng

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Context: Women with polycystic ovary syndrome (PCOS) have been implicated to have higher levels of alanine aminotransferase (ALT) because of the high prevalence of obesity. Objective: Our aim was to investigate the relationship between elevated ALT and aspartate aminotransferase (AST) activity and characteristic hyperandrogenism in women with PCOS. Design and Setting: We conducted a cross-sectional case-control study in a reproductive endocrinology clinic and voluntary annual medical health check-up program of the health management center in a tertiary medical center. Patients: A total of 279 women with PCOS and 279 age-frequency-matched healthy women were studied. Interventions: There were no interventions. Main Outcome Measures: All subjects underwent anthropometric measurement, clinical history recorded by questionnaires, and biochemical tests after an overnight fast. Results: The prevalence of elevated ALT and AST levels was significantly higher in women with PCOS than healthy control subjects. Multivariate regression analysis for women revealed that the presence of PCOS was significantly associated with elevated ALT but not AST after adjustment for age, obesity, and dyslipidemia. The level of androgenicity represented by free androgen index in women with PCOS was significantly related to elevated ALT and AST levels in multivariate regression models. Women with PCOS who had the highest quartile of free androgen index level had the highest risk of elevated ALT level after adjustment for age, obesity, insulin resistance, and dyslipidemia. Conclusions: The risk of elevated ALT level is significantly higher in women with PCOS than those without, independent of obesity. The elevated ALT levels in women with PCOS were associated with the increased androgen levels, independent of obesity, insulin resistance, and dyslipidemia.

AB - Context: Women with polycystic ovary syndrome (PCOS) have been implicated to have higher levels of alanine aminotransferase (ALT) because of the high prevalence of obesity. Objective: Our aim was to investigate the relationship between elevated ALT and aspartate aminotransferase (AST) activity and characteristic hyperandrogenism in women with PCOS. Design and Setting: We conducted a cross-sectional case-control study in a reproductive endocrinology clinic and voluntary annual medical health check-up program of the health management center in a tertiary medical center. Patients: A total of 279 women with PCOS and 279 age-frequency-matched healthy women were studied. Interventions: There were no interventions. Main Outcome Measures: All subjects underwent anthropometric measurement, clinical history recorded by questionnaires, and biochemical tests after an overnight fast. Results: The prevalence of elevated ALT and AST levels was significantly higher in women with PCOS than healthy control subjects. Multivariate regression analysis for women revealed that the presence of PCOS was significantly associated with elevated ALT but not AST after adjustment for age, obesity, and dyslipidemia. The level of androgenicity represented by free androgen index in women with PCOS was significantly related to elevated ALT and AST levels in multivariate regression models. Women with PCOS who had the highest quartile of free androgen index level had the highest risk of elevated ALT level after adjustment for age, obesity, insulin resistance, and dyslipidemia. Conclusions: The risk of elevated ALT level is significantly higher in women with PCOS than those without, independent of obesity. The elevated ALT levels in women with PCOS were associated with the increased androgen levels, independent of obesity, insulin resistance, and dyslipidemia.

UR - http://www.scopus.com/inward/record.url?scp=77954932833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954932833&partnerID=8YFLogxK

U2 - 10.1210/jc.2009-2698

DO - 10.1210/jc.2009-2698

M3 - Article

C2 - 20427499

AN - SCOPUS:77954932833

VL - 95

SP - 3332

EP - 3341

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 7

ER -